This Article Full Text (PDF) All Versions of this Article: 1352458508101935v1 15/5/613    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bichuetti, D. Articles by Gabbai, A. Search for Related Content PubMed PubMed Citation Articles by Bichuetti, D. Articles by Gabbai, A. Social Bookmarking                         What's this?

Neuromyelitis optica in Brazil: a study on clinical and prognostic factors

Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo – SP, Brazil denisbichuetti{at}globo.com

EML Oliveira

Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo – SP, Brazil

NA Souza

Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo – SP, Brazil

RLM Rivero

Department of Radiology, Federal University of São Paulo (UNIFESP), São Paulo – SP, Brazil

AA Gabbai

Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo – SP, Brazil

Objectives

To describe the clinical characteristics of patients with relapsing neuromyelitis optica (NMO) from a tertiary care center in Brazil and compare the groups with normal and abnormal brain magnetic resonance imaging (MRI).

Methods

Retrospective review of 41 patients followed at the Neuroimmunology Clinic of the Federal University of São Paulo, Brazil, from 1994 to 2007.

Results

All patients had relapsing-remitting optic-spinal disease, long extending spinal cord lesions, and brain MRI not meeting Barkhof criteria for multiple sclerosis (MS), thus fulfilling the 1999 and 2006 Wingerchuck criteria for NMO. Mean follow-up time was 52 months; mean age of onset was 32.6 years. The mean relapse rate (RR) and progression index (PI) were 1.0 and 0.9, respectively. Twenty-four patients had brain lesions not compatible with MS on MRI, and there were no statistical differences on PI and RR between patients who had brain lesions and patients who did not. Incomplete recovery, but not the type of first relapse, correlated with a worse prognosis. Seventeen patients were tested for NMO-IgG (anti-aquaporin-4 antibody) with 41% positivity.

Conclusions

In this series, we did not find a statistical difference of disease progression between patients with and without brain lesions, suggesting that the presence of brain abnormalities is not a marker of disease severity.

Key Words: demyelinating disease • epidemiology • magnetic resonance imaging • neuromyelitis optica • prognosis

This version was published on May 1, 2009

Multiple Sclerosis, Vol. 15, No. 5, 613-619 (2009)
DOI: 10.1177/1352458508101935


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?